FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

765663002: Product containing precisely bumetanide 500 microgram and potassium chloride 573 milligram/1 each prolonged-release oral tablet (clinical drug)


Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3674142015 Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3674143013 Product containing precisely bumetanide 500 microgram and potassium chloride 573 milligram/1 each prolonged-release oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3674142015 Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3674143013 Product containing precisely bumetanide 500 microgram and potassium chloride 573 milligram/1 each prolonged-release oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3674144019 Product containing precisely bumetanide 500 microgram and potassium chloride 573 milligram/1 each prolonged-release oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet Has manufactured dose form Prolonged-release oral tablet true Inferred relationship Existential restriction modifier (core metadata concept)
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet Is a Product containing bumetanide in oral dose form (medicinal product form) false Inferred relationship Existential restriction modifier (core metadata concept)
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet Has presentation strength denominator unit (attribute) Tablet (unit of presentation) true Inferred relationship Existential restriction modifier (core metadata concept) 2
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet Has presentation strength denominator value un false Inferred relationship Existential restriction modifier (core metadata concept) 2
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet Has unit of presentation Tablet (unit of presentation) true Inferred relationship Existential restriction modifier (core metadata concept)
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet Is a Potassium chloride-containing product in oral dose form false Inferred relationship Existential restriction modifier (core metadata concept)
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet Has presentation strength denominator unit (attribute) Tablet (unit of presentation) true Inferred relationship Existential restriction modifier (core metadata concept) 1
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet Has presentation strength denominator value un false Inferred relationship Existential restriction modifier (core metadata concept) 1
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet Has precise active ingredient Potassium chloride false Inferred relationship Existential restriction modifier (core metadata concept) 1
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet Has presentation strength numerator value 500 false Inferred relationship Existential restriction modifier (core metadata concept) 2
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet Has presentation strength numerator unit (attribute) mcg false Inferred relationship Existential restriction modifier (core metadata concept) 2
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet Has basis of strength substance (attribute) Bumetanide false Inferred relationship Existential restriction modifier (core metadata concept) 2
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet Has precise active ingredient Bumetanide false Inferred relationship Existential restriction modifier (core metadata concept) 2
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet Has basis of strength substance (attribute) Potassium chloride false Inferred relationship Existential restriction modifier (core metadata concept) 1
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet Has presentation strength numerator unit (attribute) mg false Inferred relationship Existential restriction modifier (core metadata concept) 1
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet Has presentation strength numerator value 573 false Inferred relationship Existential restriction modifier (core metadata concept) 1
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet Count of base of active ingredient deux false Inferred relationship Existential restriction modifier (core metadata concept)
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet Is a Bumetanide and potassium chloride only product in oral dose form true Inferred relationship Existential restriction modifier (core metadata concept)
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet Plays role Loop diuretic therapeutic role (role) false Inferred relationship Existential restriction modifier (core metadata concept)
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet Has basis of strength substance (attribute) Bumetanide true Inferred relationship Existential restriction modifier (core metadata concept) 1
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet Has precise active ingredient Bumetanide true Inferred relationship Existential restriction modifier (core metadata concept) 1
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet Has basis of strength substance (attribute) Potassium chloride true Inferred relationship Existential restriction modifier (core metadata concept) 2
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet Has presentation strength numerator unit (attribute) mcg true Inferred relationship Existential restriction modifier (core metadata concept) 1
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet Has presentation strength numerator unit (attribute) mg true Inferred relationship Existential restriction modifier (core metadata concept) 2
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet Has precise active ingredient Potassium chloride true Inferred relationship Existential restriction modifier (core metadata concept) 2

Inbound Relationships Type Active Source Characteristic Refinability Group

Reference Sets

Description inactivation indicator reference set

GB English

US English

Back to Start